BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26708556)

  • 1. Myf5 and Myogenin in the development of thymic myoid cells - Implications for a murine in vivo model of myasthenia gravis.
    Hu B; Simon-Keller K; Küffer S; Ströbel P; Braun T; Marx A; Porubsky S
    Exp Neurol; 2016 Mar; 277():76-85. PubMed ID: 26708556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.
    Spuler S; Marx A; Kirchner T; Hohlfeld R; Wekerle H
    Am J Pathol; 1994 Oct; 145(4):766-70. PubMed ID: 7943168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.
    Attia M; Maurer M; Robinet M; Le Grand F; Fadel E; Le Panse R; Butler-Browne G; Berrih-Aknin S
    Acta Neuropathol; 2017 Dec; 134(6):869-888. PubMed ID: 28756524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study.
    Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J
    Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas.
    Kornstein MJ; Asher O; Fuchs S
    Am J Pathol; 1995 Jun; 146(6):1320-4. PubMed ID: 7778671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.
    Wakkach A; Poea S; Chastre E; Gespach C; Lecerf F; De La Porte S; Tzartos S; Coulombe A; Berrih-Aknin S
    Am J Pathol; 1999 Oct; 155(4):1229-40. PubMed ID: 10514405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR is necessary for proper satellite cell activity and skeletal muscle regeneration.
    Zhang P; Liang X; Shan T; Jiang Q; Deng C; Zheng R; Kuang S
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):102-8. PubMed ID: 25998386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells.
    Matsumoto MY; Matsuo H; Oka T; Fukudome T; Hayashi K; Shiraishi H; Motomura M; Shibuya N; Ayabe H
    J Neuroimmunol; 2004 May; 150(1-2):80-7. PubMed ID: 15081251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central role of interferon-beta in thymic events leading to myasthenia gravis.
    Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic myoid cell turnover in myasthenia gravis patients and in normal controls.
    Bornemann A; Kirchner T
    Virchows Arch; 1998 Apr; 432(4):357-61. PubMed ID: 9565346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in the efficiency of lineage marking and ablation confound distinctions between myogenic cell populations.
    Comai G; Sambasivan R; Gopalakrishnan S; Tajbakhsh S
    Dev Cell; 2014 Dec; 31(5):654-67. PubMed ID: 25490270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells.
    Wekerle H; Ketelsen UP; Zurn AD; Fulpius BW
    Eur J Immunol; 1978 Aug; 8(8):579-82. PubMed ID: 699955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo.
    Bajanca F; Luz M; Raymond K; Martins GG; Sonnenberg A; Tajbakhsh S; Buckingham M; Thorsteinsdóttir S
    Development; 2006 May; 133(9):1635-44. PubMed ID: 16554364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myogenin-dependent nAChR clustering in aneural myotubes.
    Macpherson PC; Cieslak D; Goldman D
    Mol Cell Neurosci; 2006 Apr; 31(4):649-60. PubMed ID: 16443371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.